Back to the fridge
Living with it

Cold caps for every hair type

An interview-based qualitative study of scalp cooling, alopecia, and disparities in Black breast cancer patients

Minta A et al. · Supportive Care in Cancer · 2026

The big question

Scalp cooling, sometimes called a cold cap, chills the scalp during chemotherapy to help prevent hair loss. At the authors' cancer center, non-White patients with breast cancer were about six times less likely than White patients to use it. This study asked why.

What they did

Researchers held one-hour video interviews with 17 Black women with breast cancer who received chemotherapy. They talked about how hair loss affected them, how they felt about scalp cooling, and what would help. The team then sorted the conversations into common themes.

What they found

Women described key barriers: few Black women shown in scalp-cooling advertising, worries that it would not work on textured hair, and cost, which came up often. Ten of the 17 women did not use scalp cooling. Fifteen of the 17 (88.2%) had not heard of minoxidil, a medicine used to treat hair loss. Women suggested better counseling on using scalp cooling with textured hair, access to wigs and other ways to cover hair loss, financial help, and earlier referral to a skin and hair doctor (dermatologist).

Why it matters

Hair loss is deeply personal and tied to identity. Knowing these barriers can help care teams offer every patient real choices.

What it doesn't mean

This was a small study at one center, and people chose to take part. It describes experiences; it did not test how well scalp cooling works on different hair types.

Read the original abstract
Background: Existing quality-of-life assessment tools for chemotherapy-induced alopecia may not adequately serve women of all races. Non-White patients with breast cancer receiving chemotherapy at our institution were approximately six times less likely than White patients to use scalp cooling (SC). Objective: This study examines factors contributing to this disparity through interviews with Black women undergoing chemotherapy, focusing on alopecia’s impact and attitudes toward its prevention and treatment. Methods: Semi-structured, 1-hour Zoom interviews were conducted and transcribed. Content analysis using NVIVO software and a grounded theory approach identified themes. Results: Three main domains emerged: (1) alopecia’s impact, (2) barriers to SC, and (3) improving alopecia management. Key barriers included limited representation of Black women in SC advertising and concerns about SC’s effectiveness on textured hair. Solutions included better counseling on SC use, camouflage options, and increased awareness of other treatment options like dermatology referrals. Limitations: The study was conducted at a single institution; participation was voluntary leading to possible selection bias and the risk for recall bias in the setting of assessing patients’ attitudes retrospectively. Conclusion: This study highlights barriers to SC use among Black women, providing insights for developing interventions to improve access to alopecia prevention and treatment.

Abstract reproduced from Minta A et al., Supportive Care in Cancer (2026), under a CC BY 4.0 license. Plain-English summary by Womanhattan.

This summary was written with AI assistance and checked against the original paper. It is for learning, not medical advice. Talk with your care team before changing anything about your health or treatment.